Meeder Asset Management Inc Avalo Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

  • $1.48 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
BUY
$3.0 - $10.45 $1,980 - $6,896
660 Added 3.79%
18,082 $9,000
Q1 2022

May 10, 2022
BUY
$7.57 - $21.72 $131,884 - $378,405
17,422 New
17,422 $13,000
Q4 2021

Feb 11, 2022
SELL
$19.68 - $28.68 $379,036 - $552,376
-19,260 Closed
0 $0
Q3 2021

Nov 08, 2021
BUY
$26.16 - $40.68 $503,841 - $783,496
19,260 New
19,260 $43,000

Others Institutions Holding AVTX

# of Institutions
1
Shares Held
34.6K
Call Options Held
0
Put Options Held
0
View Full List

About Avalo Therapeutics, Inc.

AVTX Quotes by TradingView
  • Ticker AVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,414,100
  • Market Cap $84.9M
  • Description
  • Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the tr...
More about AVTX
Track This Portfolio

Track Meeder Asset Management Inc Portfolio

Follow Meeder Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email